You are here

  • Home
  • Archive
  • Volume 9, Issue 4
  • Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer

Article metrics

Article menu

Download PDFPDF

Immunotherapy biomarkers
Comparison of programmed death-ligand 1 protein expression between primary and metastatic lesions in patients with lung cancer

 

Online download statistics by month:

Online download statistics by month: April 2021 to July 2025

AbstractFullPdf
Apr 2021399399206
May 202116216269
Jun 202110710725
Jul 202110910919
Aug 2021919129
Sep 2021595911
Oct 202110310343
Nov 2021767827
Dec 2021989817
Jan 2022737723
Feb 2022454720
Mar 2022333312
Apr 2022586017
May 2022737523
Jun 202265659
Jul 2022798118
Aug 2022879016
Sep 2022808117
Oct 2022757612
Nov 2022677018
Dec 2022818113
Jan 2023444411
Feb 2023696918
Mar 2023303223
Apr 2023272810
May 202327277
Jun 2023232313
Jul 2023282914
Aug 2023242412
Sep 2023252512
Oct 2023262616
Nov 2023242411
Dec 2023636419
Jan 2024202213
Feb 2024393921
Mar 2024212142
Apr 2024181815
May 2024222317
Jun 2024282722
Jul 2024363718
Aug 2024262514
Sep 2024181810
Oct 2024262623
Nov 2024242521
Dec 2024424321
Jan 202534359
Feb 2025333316
Mar 2025292919
Apr 2025525217
May 2025323218
Jun 2025282915
Jul 2025110
Total295929921141